Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 14/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | DNTT | P04053 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | POLA1 | P09884 | 2/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | MPEG1 | Q2M385 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL447146 | 0.52 | TSHR (0.73) | — | |
| Octane SCHEMBL4441366 | 0.52 | TSHR (0.73) | — | |
| Hexadecane SCHEMBL27375271 | 0.52 | TSHR (0.73) | — | |
| Decane SCHEMBL3182487 | 0.52 | TSHR (0.73) | — | |
| Undecane SCHEMBL28043835 | 0.52 | TSHR (0.73) | — | |
| Octane SCHEMBL26632661 | 0.51 | — | — | |
| SCHEMBL17008157 | 0.50 | TSHR (0.57) | PTGS2 | |
| SCHEMBL23849704 | 0.50 | ESR1 (0.77) | PTGS2 | |
| Decane SCHEMBL11227696 | 0.49 | TSHR (0.80) | — | |
| Nonane SCHEMBL11226977 | 0.49 | TSHR (0.80) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3274322-B1 | STABLE COMPOSITIONS FOR PREVENTION / PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIV OF MISSISSIPPI (US) | 2024-08-14 | — | — | EP | disclosed |
| US-10322103-B2 | Compositions for prevention/prophylactic treatment of poison ivy dermatitis | UNIVERSITY OF MISSISSIPPI (US) | 2019-06-18 | — | — | US | disclosed |
| US-20180078520-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | UNIVERSITY OF MISSISSIPPI | 2018-03-22 | — | — | US | disclosed |
| EP-3274322-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | The University Of Mississippi (US) | 2018-01-31 | — | — | EP | disclosed |
| WO-2016160090-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIVERSITY OF MISSISSIPPI (US) | 2016-10-06 | — | — | WO | disclosed |
| US-9408822-B2 | Compositions for prevention/prophylactic treatment of poison ivy dermatitis | THE UNIVERSITY OF MISSISSIPPI (US) | 2016-08-09 | — | — | US | disclosed |
| US-20150202176-A1 | Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis | THE UNIVERSITY OF MISSISSIPPI | 2015-07-23 | — | — | US | disclosed |
| US-9029417-B2 | Compositions for prevention/prophylactic treatment of poison ivy dermatitis | THE UNIVERSITY OF MISSISSIPPI (US) | 2015-05-12 | — | — | US | disclosed |
| US-20130303582-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIVERSITY OF MISSISSIPPI | 2013-11-14 | — | — | US | disclosed |
| US-8486998-B2 | Compositions for prevention/prophylactic treatment of poison ivy dermatitis | THE UNIVERSITY OF MISSISSIPPI (US) | 2013-07-16 | — | — | US | disclosed |
| US-20110086900-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIVERSITY OF MISSISSIPPI | 2011-04-14 | — | — | US | disclosed |
| WO-2009146131-A2 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIVERSITY OF MISSISSIPPI (US) | 2009-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303582-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | UGT1A3, IL33, ITCH | ALOX5 103/4885PTGS2 883/4885GBA1 2397/4885 |
| US-20150202176-A1 | Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis | UGT1A3, IL33, ITCH | ALOX5 103/4885PTGS2 883/4885GBA1 2397/4885 |
| US-20180078520-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | UGT1A3, ITCH, UGT1A1 | ALOX5 146/4885PTGS2 1062/4885GBA1 3154/4885 |
| US-10322103-B2 | Compositions for prevention/prophylactic treatment of poison ivy dermatitis | UGT1A3, ITCH, UGT1A1 | ALOX5 146/4885PTGS2 1062/4885GBA1 3154/4885 |
| US-20110086900-A1 | COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | UGT1A3, IL33, ITCH | ALOX5 103/4885PTGS2 883/4885GBA1 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.